Health Notices




8 APRIL

NEW ZEALAND GAZETTE

1025

Head Office (ASB Bank House, 101-103 The Terrace, Wellington (P.O. Box 2526, Wellington)).

Feltex House (Feltex House, 156–158 Victoria Street, Wellington (P.O. Box 297, Wellington)).

Whangarei (17 Keyte Street, Kensington (Private Bag)).

Auckland (23 Hargreaves Street, College Hill (P.O. Box 3437)).

Tauranga (corner of Elizabeth and Durham Streets (P.O. Box 13-125)).

Napier (Waghorne Street, Ahuriri (P.O. Box 12-034)).

Nelson (118 Vickerman Street (Private Bag 14)).

Christchurch (Unit 2, 585 Wairakei Road, Christchurch (P.O. Box 8324)).

Dunedin (45 Filleul Street (Private Bag 1926)).

Invercargill (137 Spey Street (P.O. Box 1065)).

Dated at Wellington this 6th day of April 1999.

D. J. WOODS, Deputy Manager Compliance, In exercise of delegated authority.

go2602


Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Lithium succinate 8% w/w Shampoo J Pickles & Sons, Knaresborough, Yorkshire, England, and Formula Products Limited, Northcote, Auckland Efalith
Ibuprofen 20 mg/mL Suspension, oral The Boots Company Plc., Beeston, Nottingham, United Kingdom Nurofen for Children
Factor II 500 IU, factor IX 500 IU, factor X 500 IU with water for injection 20 mL as diluent Injection, powder with diluent CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia Diluent: Pharmacia & Upjohn (Perth) Pty Limited, Bentley, Western Australia, Australia Prothrombinex-HT

Note: This product has provisional consent

Dated this 31st day of March 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go2618


Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Salbutamol sulphate 120.5 µg/dose equivalent to 100 µg/dose salbutamol Inhalation, powder Orion Corporation, Espoo, Finland Buventol Easyhaler
Salbutamol sulphate 241 µg/dose equivalent to 200 µg/dose salbutamol Inhalation, powder Orion Corporation, Espoo, Finland Buventol Forte Easyhaler
Felodipine 2.5 mg, ramipril 2.5 mg; felodipine 5 mg, ramipril 5 mg Tablets, film coated Astra Pharmaceutical Production AB., Sodertalje, Sweden Unimax

Dated this 31st day of March 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go2619



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 42


NZLII PDF NZ Gazette 1999, No 42





✨ LLM interpretation of page content

Issue of a Satellite Vessel Monitoring Circular

Fisheries
6 April 1999
Fisheries, Satellite Vessel Monitoring, Circular Issue
  • D. J. Woods, Deputy Manager Compliance

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
31 March 1999
Medicines, Distribution, Consent, Lithium succinate, Ibuprofen, Factor II, Factor IX, Factor X
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
31 March 1999
Medicines, Distribution, Consent, Salbutamol sulphate, Felodipine, Ramipril
  • G. R. Boyd, Chief Advisor, Regulation and Safety